The Novo Nordisk company is stopping the production of human insulin pen-type insulin syringes, affecting people with type 1 diabetes.
Călin Nicolescu
Health
Foto Pixabay
Always see our news on Google
People with type 1 diabetes who depend on human insulin made by Novo Nordisk will instead be given glass vials and syringes - said to be inconvenient and harder to use with the same precision. Novo Nordisk has already stopped supply in South Africa, where patients have had to switch to glass vials. Novo Nordisk's decision is linked to its favoring of the marketing of the slimming drugs Ozempic and Wegovy.
Sources
O companie farmaceutică ar fi oprit producţia de seringi cu insulină pentru a vinde produse de slăbit
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk, compania producătoare de medicamente folosite pentru pierderea în greutate, acuzată că prioritizează profiturile după oprirea producției de stilouri cu insulină
Latest News
15:48
Turkish commercial ships attacked with drones in the Black Sea. Ankara condemns the incidents.
15:45
The Ministry of Finance is preparing for the Moody's evaluation, after maintaining the rating from Fitch.
15:39
A 70-year-old man died after being hit by a car on Calea Dorobanți in Bucharest.
15:30
Mihai Stoica, the president of FCSB, announces that the team will bring in a new foreign striker after being eliminated from the Conference League
15:28
Fire on board a vessel with migrants in the English Channel: 157 people rescued by the French Coast Guard
See more news
NEWS ON THE SAME TOPICS
International
The European Medicines Agency has recommended the approval of the Wegovy tablet, a weight loss medication from Novo Nordisk.
Current Affairs
The company that produces Mounjaro warns that a counterfeit treatment with the same name is being sold on the market in Romania as a supplement.
Health
Brazil suspends the world's first vaccine against dengue fever after two deaths under investigation
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
